Terms: = Gastric cancer AND SMAD3, JV15-2, 4088, ENSG00000166949, P84022, Smad3, MADH3, HsT17436, Smad 3, DKFZp686J10186, HSPC193, DKFZP586N0721, MGC60396 AND Prognosis
12 results:
1. The emerging roles of CEACAM6 in human cancer (Review).
Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
[TBL] [Abstract] [Full Text] [Related]
2. Knockdown of Secernin 1 inhibit cell invasion and migration by activating the TGF-β/smad3 pathway in oral squamous cell carcinomas.
Xiao L; Zhang T; Zheng K; Xiao Q; Zhang W; Zhang D; Wu D; He C; Zhou Y; Liu Y
Sci Rep; 2023 Sep; 13(1):14922. PubMed ID: 37691034
[TBL] [Abstract] [Full Text] [Related]
3. Potential mechanisms and prognostic model of eRNAs-regulated genes in stomach adenocarcinoma.
Gao L; Rong H
Sci Rep; 2022 Oct; 12(1):16545. PubMed ID: 36192427
[TBL] [Abstract] [Full Text] [Related]
4. Downregulation of TRIM33 Promotes Survival and Epithelial-Mesenchymal Transition in gastric cancer.
Wang F; Wang W; Wu X; Tang C; Du F; Lu Z; Zhang Z; Xu H; Cao X; Li PA
Technol Cancer Res Treat; 2022; 21():15330338221114505. PubMed ID: 35929141
[TBL] [Abstract] [Full Text] [Related]
5. Golgi scaffold protein PAQR3 as a candidate suppressor of gastric cardia adenocarcinoma via regulating TGF-β/smad pathway.
Wu YL; Hong LL; Ling ZN; Hu XY; Liu Z; Li P; Ling ZQ
J Clin Lab Anal; 2022 Sep; 36(9):e24617. PubMed ID: 35870178
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic value of small mother against decapentaplegic expression in human gastric cancer.
Zhang HW; Guo Y; Sun LX; Ni FB; Xu K
Bioengineered; 2021 Dec; 12(1):2534-2549. PubMed ID: 34138687
[TBL] [Abstract] [Full Text] [Related]
7. Long Noncoding RNA
Sakai S; Ohhata T; Kitagawa K; Uchida C; Aoshima T; Niida H; Suzuki T; Inoue Y; Miyazawa K; Kitagawa M
Cancer Res; 2019 Jun; 79(11):2821-2838. PubMed ID: 30952633
[TBL] [Abstract] [Full Text] [Related]
8. EPB41L5 Mediates TGFβ-Induced Metastasis of gastric cancer.
Jeong MH; Park SY; Lee SH; Seo J; Yoo JY; Park SH; Kim MJ; Lee S; Jang S; Choi HK; Lee JE; Shin SJ; Choi KC; Cheong JH; Yoon HG
Clin Cancer Res; 2019 Jun; 25(12):3617-3629. PubMed ID: 30814110
[TBL] [Abstract] [Full Text] [Related]
9. WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies.
Aldaz CM; Ferguson BW; Abba MC
Biochim Biophys Acta; 2014 Aug; 1846(1):188-200. PubMed ID: 24932569
[TBL] [Abstract] [Full Text] [Related]
10. smad3 and smad3 phosphoisoforms are prognostic markers of gastric carcinoma.
Kim SH; Kim KH; Ahn S; Hyeon J; Park CK
Dig Dis Sci; 2013 Apr; 58(4):989-97. PubMed ID: 23179147
[TBL] [Abstract] [Full Text] [Related]
11. Decreased levels of active smad2 correlate with poor prognosis in gastric cancer.
Wu Y; Li Q; Zhou X; Yu J; Mu Y; Munker S; Xu C; Shen Z; Müllenbach R; Liu Y; Li L; Gretz N; Zieker D; Li J; Matsuzaki K; Li Y; Dooley S; Weng H
PLoS One; 2012; 7(4):e35684. PubMed ID: 22539990
[TBL] [Abstract] [Full Text] [Related]
12. SKI and MEL1 cooperate to inhibit transforming growth factor-beta signal in gastric cancer cells.
Takahata M; Inoue Y; Tsuda H; Imoto I; Koinuma D; Hayashi M; Ichikura T; Yamori T; Nagasaki K; Yoshida M; Matsuoka M; Morishita K; Yuki K; Hanyu A; Miyazawa K; Inazawa J; Miyazono K; Imamura T
J Biol Chem; 2009 Jan; 284(5):3334-3344. PubMed ID: 19049980
[TBL] [Abstract] [Full Text] [Related]
